Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is The Consultant & Investment Group EV-to-EBITDA?
The Consultant & Investment GroupAMM:CICO 77 EV-to-EBITDA is 11.63 as of Jul. 15, 2026, which is 29% below its 10-year median of 16.37. GuruFocus rates AMM:CICO with a GF Score™ of 77/100 and a GF Value™ of JOD2.21 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 507 Healthcare Providers & Services companies, The Consultant & Investment Group ranks worse than 53.65% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, The Consultant & Investment Group's enterprise value is JOD48.14 Mil.
The Consultant & Investment Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was JOD4.14 Mil. Therefore, The Consultant & Investment Group's EV-to-EBITDA for today is 11.63.
The historical rank and industry rank for The Consultant & Investment Group's EV-to-EBITDA or its related term are showing as below:
AMM:CICO'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -63.33 Med: 16.37 Max: 33389.5
Current: 11.63
During the past 13 years, the highest EV-to-EBITDA of The Consultant & Investment Group was 33389.50. The lowest was -63.33. And the median was 16.37.
AMM:CICO's EV-to-EBITDA is ranked worse than 53.65% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 10.89
vs AMM:CICO: 11.63
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
The Consultant & Investment Group (AMM:CICO) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The Consultant & Investment Group's PE Ratio (TTM) for today is calculated as:
The Consultant & Investment Group's share price for today is JOD1.78.
The Consultant & Investment Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD0.084.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Consultant & Investment Group EV-to-EBITDA Chart
AMM:CICO vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, The Consultant & Investment Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Consultant & Investment Group EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Consultant & Investment Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where The Consultant & Investment Group's EV-to-EBITDA falls into.
The Consultant & Investment Group's current Enterprise Value is JOD48.14 Mil.
The Consultant & Investment Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was JOD4.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Consultant & Investment Group (AMM:CICO) has a EV-to-EBITDA of 11.63 as of Jul. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on The Consultant & Investment Group. This is 29% below median its historical median of 16.37. According to the industry distribution chart, The Consultant & Investment Group ranks #272 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 53.6%.
Is The Consultant & Investment Group's EV-to-EBITDA too high?
The Consultant & Investment Group's current EV-to-EBITDA of 11.63 is 29% below median its 10-year median of 16.37. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.89. The Consultant & Investment Group's value of 11.63 is 6.8% above this industry median. Based on the distribution chart, The Consultant & Investment Group ranks #272 out of 507 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, The Consultant & Investment Group has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Consultant & Investment Group's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, The Consultant & Investment Group ranks #272 out of 507 companies for EV-to-EBITDA. This places The Consultant & Investment Group in the lower half of its industry. The industry median EV-to-EBITDA is 10.89. The Consultant & Investment Group's value of 11.63 is 6.8% above this benchmark. While the company's 10-year median is 16.37 vs. the industry median of 10.89, The Consultant & Investment Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.89, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Consultant & Investment Group's current EV-to-EBITDA of 11.63 is 6.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on The Consultant & Investment Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Consultant & Investment Group's current EV-to-EBITDA is 11.63, which is 29% below median its own 10-year median of 16.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Consultant & Investment Group stock overvalued right now?
Based on GuruFocus' analysis, The Consultant & Investment Group (AMM:CICO) is currently considered Modestly Undervalued. The stock's GF Value™ is JOD2.21, compared to a current price of JOD1.78 — trading 19.5% below its estimated fair value. The current EV-to-EBITDA is 11.63, which is 29% below median its 10-year median of 16.37 and 6.8% above the Healthcare Providers & Services industry median of 10.89. The Consultant & Investment Group's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For The Consultant & Investment Group (AMM:CICO), the current EV-to-EBITDA is 11.63 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Consultant & Investment Group (AMM:CICO) Overvalued in 2026?
Based on GuruFocus' analysis, The Consultant & Investment Group stock appears to be undervalued.
The current stock price of JOD1.78 is trading 19.5% below its estimated GF Value™ of JOD2.21.
GuruFocus considers The Consultant & Investment Group to be Modestly Undervalued.
Key valuation signals for AMM:CICO:
EV-to-EBITDA: 11.63 (29% below median its 10-year median of 16.37)
GF Value™: JOD2.21 vs. price of JOD1.78 (19.5% below fair value)
Industry Position: 6.8% above the Healthcare Providers & Services median (#272 of 507)
No single metric tells the full story. See the AMM:CICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Consultant & Investment Group Business Description
The Consultant & Investment Group is a Jordan-based company that engages in the healthcare and medical sector. It is engaged in the provision of medical care services. The company generates revenue from medical services and the sale of medicine and medical/ supplies are recognized. The company gains majority of revenue from Jordan. The Group principally operates only in the Hashemite Kingdom of Jordan.
77GF Score
Get the complete analysis for AMM:CICO
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:CICO has been successfully added to your 
